v3.26.1
Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Commited equity facility
Third party issuance
Equity offering
Ordinary shares
Ordinary shares
Commited equity facility
Ordinary shares
Third party issuance
Ordinary shares
Equity offering
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Jun. 30, 2023         64,747,477            
Beginning balance at Jun. 30, 2023 $ 305,448       $ 965,857       $ 28,435 $ (654,189) $ (34,655)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of ordinary shares (in shares)         108,063,868 12,887,814 106,687        
Issuance of ordinary shares 746,999 $ 49,717 $ 319   $ 746,999 $ 49,717 $ 319        
Issuance of Ordinary shares – restricted stock units (in shares)         104,559            
Issuance of Ordinary shares – restricted stock units 118       $ 118            
Issuance of Ordinary shares - stock options (in shares)         457,281            
Issuance of Ordinary shares – stock options 1,279       $ 1,279            
Stock-based compensation 22,851               22,851    
Other comprehensive income (loss) (339)                   (339)
Net income (loss) (28,920)                 (28,920)  
Ending balance (in shares) at Jun. 30, 2024         186,367,686            
Ending balance at Jun. 30, 2024 1,097,471       $ 1,764,289       51,286 (683,109) (34,994)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of ordinary shares (in shares)         69,074,101            
Issuance of ordinary shares 584,747       $ 584,747            
Issuance of Ordinary shares – restricted stock units (in shares)         1,770,112            
Issuance of Ordinary shares – restricted stock units 6,020       $ 6,020            
Stock-based compensation 37,386               37,386    
Other comprehensive income (loss) 4,921                   4,921
Net income (loss) 86,941                 86,941  
Ending balance (in shares) at Jun. 30, 2025         257,211,899            
Ending balance at Jun. 30, 2025 1,817,488       $ 2,355,056       88,672 (596,167) (30,073)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of ordinary shares (in shares)         70,206,940     39,699,102      
Issuance of ordinary shares 3,058,036     $ 1,631,451 $ 3,058,036     $ 1,631,451      
Issuance of Ordinary shares – restricted stock units (in shares)         9,863,884            
Issuance of Ordinary shares – restricted stock units 71,803       $ 71,803            
Issuance of Ordinary shares - stock options (in shares)         2,374,359            
Issuance of Ordinary shares – stock options 9,051       $ 9,051            
Issuance of Ordinary shares – Nostrum acquisition (in shares)         837,424            
Issuance of Ordinary shares – Nostrum acquisition 47,490       $ 47,490            
Stock-based compensation 131,474               131,474    
Repurchase of the 2030 Convertible Notes and 2029 Convertible Notes (981,018)               (981,018)    
Reclassification of 2030 Prepaid Forward Contract and 2029 Prepaid Forward Contract (665,400)               (665,400)    
Reclassification of 2030 Capped Call Transactions and 2029 Capped Call Transactions (259,600)               (259,600)    
Settlement of 2029 Capped Call Transactions 38,811               38,811    
Other comprehensive income (loss) (11,351)                   (11,351)
Net income (loss) (702,621)                 (702,621)  
Ending balance (in shares) at Jun. 30, 2026         380,193,608            
Ending balance at Jun. 30, 2026 $ 4,185,613       $ 7,172,887       $ (1,647,061) $ (1,298,789) $ (41,424)